See also this year's filing and all EDGAR filings for this company.
PDF Report 0001516551_2021_Skye_Bioscience_Inc.pdf
Logs
warning | Missing logo | subcommand.report | {} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001516551')"} |
Graph
Absolute values for 0001516551, Skye Bioscience Inc.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 2,664,385 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 7,341 |
3 | remainder_Assets | 0 |
4 | LiabilitiesCurrent | 787,199 |
5 | LiabilitiesNoncurrent | 0 |
6 | remainder_Liabilities | 1,433,741 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 4,344,602 |
9 | ResearchAndDevelopmentExpense | 1,944,411 |
10 | remainder_Expenses | 1,600 |
11 | remainder_Revenues | 0 |
12 | remainder_NetIncome | -270,086 |
13 | remainder_ComprehensiveNetIncome | 0 |
yvar | yval | |
---|---|---|
0 | Assets | 2,671,726 |
1 | Liabilities | 2,220,940 |
2 | Expenses | 6,290,613 |
3 | Revenues | 0 |
4 | StockholdersEquity | 450,786 |
5 | NetIncome | -6,560,699 |
6 | ComprehensiveNetIncome | -6,560,699 |
7 | BaseVar | 5,726,682 |
8 | EconomicCapitalRatio | -2.36 |